252 related articles for article (PubMed ID: 30985083)
21. Process intensification for the production of rituximab by an inducible CHO cell line.
Mellahi K; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
Bioprocess Biosyst Eng; 2019 May; 42(5):711-725. PubMed ID: 30673843
[TBL] [Abstract][Full Text] [Related]
22. Development of a novel, high-throughput screening tool for efficient perfusion-based cell culture process development.
Gagliardi TM; Chelikani R; Yang Y; Tuozzolo G; Yuan H
Biotechnol Prog; 2019 Jul; 35(4):e2811. PubMed ID: 30932357
[TBL] [Abstract][Full Text] [Related]
23. Platform development for high-throughput optimization of perfusion processes-Part II: Variation of perfusion rate strategies in microwell plates.
Dorn M; Lucas C; Klottrup-Rees K; Lee K; Micheletti M
Biotechnol Bioeng; 2024 Jun; 121(6):1774-1788. PubMed ID: 38433473
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
[TBL] [Abstract][Full Text] [Related]
25. Rapid development of clone-specific, high-performing perfusion media from established feed supplements.
Mayrhofer P; Reinhart D; Castan A; Kunert R
Biotechnol Prog; 2020 Mar; 36(2):e2933. PubMed ID: 31680446
[TBL] [Abstract][Full Text] [Related]
26. A high-throughput media design approach for high performance mammalian fed-batch cultures.
Rouiller Y; Périlleux A; Collet N; Jordan M; Stettler M; Broly H
MAbs; 2013; 5(3):501-11. PubMed ID: 23563583
[TBL] [Abstract][Full Text] [Related]
27. Production of butyrate and branched-chain amino acid catabolic byproducts by CHO cells in fed-batch culture enhances their specific productivity.
Harrington C; Jacobs M; Bethune Q; Kalomeris T; Hiller GW; Mulukutla BC
Biotechnol Bioeng; 2021 Dec; 118(12):4786-4799. PubMed ID: 34569627
[TBL] [Abstract][Full Text] [Related]
28. A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media.
Robitaille J; Chen J; Jolicoeur M
PLoS One; 2015; 10(9):e0136815. PubMed ID: 26331955
[TBL] [Abstract][Full Text] [Related]
29. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
[TBL] [Abstract][Full Text] [Related]
30. Autophagy-inducing peptide increases CHO cell monoclonal antibody production in batch and fed-batch cultures.
Braasch K; Kryworuchko M; Piret JM
Biotechnol Bioeng; 2021 May; 118(5):1876-1883. PubMed ID: 33543765
[TBL] [Abstract][Full Text] [Related]
31. Effects of pyruvate on primary metabolism and product quality for a high-density perfusion process.
Caso S; Aeby M; Jordan M; Guillot R; Bielser JM
Biotechnol Bioeng; 2022 Apr; 119(4):1053-1061. PubMed ID: 35023143
[TBL] [Abstract][Full Text] [Related]
32. Identification and control of novel growth inhibitors in fed-batch cultures of Chinese hamster ovary cells.
Mulukutla BC; Kale J; Kalomeris T; Jacobs M; Hiller GW
Biotechnol Bioeng; 2017 Aug; 114(8):1779-1790. PubMed ID: 28409820
[TBL] [Abstract][Full Text] [Related]
33. Improvement and simplification of fed-batch bioprocesses with a highly soluble phosphotyrosine sodium salt.
Zimmer A; Mueller R; Wehsling M; Schnellbaecher A; von Hagen J
J Biotechnol; 2014 Sep; 186():110-8. PubMed ID: 25014403
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
35. Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors.
Kildegaard HF; Fan Y; Sen JW; Larsen B; Andersen MR
Biotechnol Bioeng; 2016 Feb; 113(2):359-66. PubMed ID: 26222761
[TBL] [Abstract][Full Text] [Related]
36. S-Sulfocysteine simplifies fed-batch processes and increases the CHO specific productivity via anti-oxidant activity.
Hecklau C; Pering S; Seibel R; Schnellbaecher A; Wehsling M; Eichhorn T; Hagen Jv; Zimmer A
J Biotechnol; 2016 Jan; 218():53-63. PubMed ID: 26654938
[TBL] [Abstract][Full Text] [Related]
37. Lipidomics of CHO Cell Bioprocessing: Relation to Cell Growth and Specific Productivity of a Monoclonal Antibody.
Ali AS; Raju R; Ray S; Kshirsagar R; Gilbert A; Zang L; Karger BL
Biotechnol J; 2018 Oct; 13(10):e1700745. PubMed ID: 29521466
[TBL] [Abstract][Full Text] [Related]
38. Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality.
Schulze M; Lemke J; Pollard D; Wijffels RH; Matuszczyk J; Martens DE
J Biotechnol; 2021 Jul; 335():65-75. PubMed ID: 34090946
[TBL] [Abstract][Full Text] [Related]
39. The "push-to-low" approach for optimization of high-density perfusion cultures of animal cells.
Konstantinov K; Goudar C; Ng M; Meneses R; Thrift J; Chuppa S; Matanguihan C; Michaels J; Naveh D
Adv Biochem Eng Biotechnol; 2006; 101():75-98. PubMed ID: 16989258
[TBL] [Abstract][Full Text] [Related]
40. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production.
Mahé A; Martiné A; Fagète S; Girod PA
Bioprocess Biosyst Eng; 2022 Feb; 45(2):297-307. PubMed ID: 34750672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
